We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+25.59%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$30.2M
Cap. Flow
+$9.62M
Cap. Flow %
7.73%
Top 10 Hldgs %
42.82%
Holding
77
New
12
Increased
24
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$3.44M
2
INTT icon
inTEST
INTT
+$1.59M
3
PFE icon
Pfizer
PFE
+$1.51M
4
OGN icon
Organon & Co
OGN
+$1.5M
5
NWL icon
Newell Brands
NWL
+$1.33M

Top Sells

Rank Stock Value
1
NHC icon
National Healthcare
NHC
+$3.45M
2
SWN
Southwestern Energy Company
SWN
+$2.1M
3
TALO icon
Talos Energy
TALO
+$1.9M
4
DRRX
DURECT Corp
DRRX
+$1.31M
5
FNF icon
Fidelity National Financial
FNF
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 44.16%
2 Financials 8.39%
3 Technology 8.19%
4 Industrials 7.86%
5 Materials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
1
DELISTED
Immunogen Inc
IMGN
$14.8M 11.91%
500,000
– –
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
$6.39M 5.13%
450,000
– –
ALCO icon
3
Alico
ALCO
$300M
$6.25M 5.02%
215,000
– –
RLGT icon
4
Radiant Logistics
RLGT
$395M
$4.58M 3.68%
690,000
+70,000
+11% +$424K
NMRK icon
5
Newmark Group
NMRK
$2.76B
$4.38M 3.52%
400,000
+50,000
+14% +$378K
BGC icon
6
BGC Group
BGC
$5.79B
$4.15M 3.34%
575,000
-75,000
-12% -$464K
RPRX icon
7
Royalty Pharma
RPRX
$28.5B
$3.51M 2.82%
+125,000
New +$3.44M
TGB
8
Trekor Metals
TGB
$3.09B
$3.5M 2.81%
2,500,000
– –
KD icon
9
Kyndryl
KD
$2.86B
$2.91M 2.34%
140,000
+40,000
+40% +$684K
PD icon
10
PagerDuty
PD
$1.07B
$2.78M 2.23%
120,000
+60,000
+100% +$1.3M
NHC icon
11
National Healthcare
NHC
$3.42B
$2.77M 2.23%
30,000
-45,000
-60% -$3.45M
TAST
12
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.76M 2.22%
350,000
– –
CHRS icon
13
Coherus Oncology
CHRS
$219M
$2.74M 2.21%
824,000
+276,000
+50% +$739K
ARKR icon
14
Ark Restaurants
ARKR
$19.2M
$2.6M 2.09%
184,607
– –
RIGL icon
15
Rigel Pharmaceuticals
RIGL
$909M
$2.46M 1.98%
170,000
+20,000
+13% +$205K
PLPC icon
16
Preformed Line Products
PLPC
$1.95B
$2.34M 1.88%
17,500
– –
ARKO icon
17
ARKO Corp
ARKO
$549M
$2.17M 1.75%
610,000
+20,000
+3% +$153K
AMSC icon
18
American Superconductor
AMSC
$1.43B
$2.17M 1.75%
195,000
-5,000
-3% -$42.3K
VTRS icon
19
Viatris
VTRS
$19.4B
$2.17M 1.74%
200,000
+75,000
+60% +$718K
SVC
20
Service Properties Trust
SVC
$986M
$2.13M 1.72%
50,000
+20,000
+67% +$756K
FCX icon
21
Freeport-McMoran
FCX
$104B
$2.13M 1.71%
50,000
+14,000
+39% +$517K
IOVA icon
22
Iovance Biotherapeutics
IOVA
$3.98B
$2.03M 1.63%
250,000
+50,000
+25% +$262K
BRKL
23
DELISTED
Brookline Bancorp
BRKL
$1.96M 1.58%
180,000
– –
OGN icon
24
Organon & Co
OGN
$3.62B
$1.8M 1.45%
125,000
+110,000
+733% +$1.5M
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
$1.7M 1.36%
65,000
+25,000
+63% +$559K
1
2 3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q4 2023 Portfolio in Review

As of Q4 2023, CM Management held 77 positions worth $124M, up 32% from $94.2M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

CM Management deployed $9.62M of net new capital in Q4 2023, opening 12 new positions and adding to 24 existing holdings. Its largest new stake was Royalty Pharma: 125,000 shares worth $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was National Healthcare, an estimated $3.45M trimmed.

  • CM Management's largest Q4 2023 buy was Royalty Pharma: 125,000 shares worth $3.51M.
  • CM Management added most to Organon & Co in Q4 2023, an estimated $1.5M increase.
  • CM Management's biggest Q4 2023 reduction was National Healthcare, cutting an estimated $3.45M.
  • CM Management fully exited Southwestern Energy Company in Q4 2023, selling an estimated $2.1M.
  • CM Management's ten largest holdings make up 43% of its $124M portfolio in Q4 2023.
  • CM Management opened 12 new positions and closed 5 in Q4 2023.
  • CM Management's portfolio value rose 32% quarter-over-quarter to $124M.

Based on CM Management's 13F filing for Q4 2023, filed 12 Feb 2024.